Increasingly, economic data are being considered in formulary decisions. In oncology, pharmacoeconomic evaluations are essential to help decision makers weigh the associated costs and outcomes of competing
Tom Einarson, PhD
Advertisement
Articles by Tom Einarson, PhD
Advertisement
Latest Updated Articles
- Economic and Quality of Life Outcomes: The Four-Step Pharmacoeconomic Research Model
Published: November 1st 1995 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Sac-TMT Combo Produces Encouraging Activity in Pretreated Metastatic CRPC
2
Zurletrectinib Generates Responses in Advanced NTRK Fusion Solid Tumors
3
How Will Gastrointestinal Cancer Standards of Care Change? An ESMO Recap
4
Molecular Insights Into Cancer Cachexia: An Evolution in Identifying the Syndrome
5
